These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33011679)

  • 1. In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer.
    Li X; Jeon YH; Kwon N; Park JG; Guo T; Kim HR; Huang JD; Lee DS; Yoon J
    Biomaterials; 2021 Jan; 266():120430. PubMed ID: 33011679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
    Kaneko K; Acharya CR; Nagata H; Yang X; Hartman ZC; Hobeika A; Hughes PF; Haystead TAJ; Morse MA; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
    Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy.
    Wang D; Wang T; Liu J; Yu H; Jiao S; Feng B; Zhou F; Fu Y; Yin Q; Zhang P; Zhang Z; Zhou Z; Li Y
    Nano Lett; 2016 Sep; 16(9):5503-13. PubMed ID: 27525587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
    Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
    ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nanostructured Phthalocyanine/Albumin Supramolecular Assembly for Fluorescence Turn-On Imaging and Photodynamic Immunotherapy.
    Wang R; Kim KH; Yoo J; Li X; Kwon N; Jeon YH; Shin SK; Han SS; Lee DS; Yoon J
    ACS Nano; 2022 Feb; 16(2):3045-3058. PubMed ID: 35089696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
    Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
    Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
    He Z; Dai Y; Li X; Guo D; Liu Y; Huang X; Jiang J; Wang S; Zhu G; Zhang F; Lin L; Zhu JJ; Yu G; Chen X
    Small; 2019 Jan; 15(4):e1804131. PubMed ID: 30565431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer.
    Gao A; Chen B; Gao J; Zhou F; Saeed M; Hou B; Li Y; Yu H
    Nano Lett; 2020 Jan; 20(1):353-362. PubMed ID: 31793787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the Release Efficiency of a Molecular Chemotherapeutic Prodrug by Photodynamic Therapy.
    Yuan J; Zhou QH; Xu S; Zuo QP; Li W; Zhang XX; Ren TB; Yuan L; Zhang XB
    Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206169. PubMed ID: 35688800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
    Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
    ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting.
    Li H; Deng C; Tan Y; Dong J; Zhao Y; Wang X; Yang X; Luo J; Gao H; Huang Y; Zhang ZR; Gong T
    Acta Biomater; 2022 Jul; 146():357-369. PubMed ID: 35577045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem activated photodynamic and chemotherapy: Using pH-Sensitive nanosystems to realize different tumour distributions of photosensitizer/prodrug for amplified combination therapy.
    Ji Y; Lu F; Hu W; Zhao H; Tang Y; Li B; Hu X; Li X; Lu X; Fan Q; Huang W
    Biomaterials; 2019 Oct; 219():119393. PubMed ID: 31382206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
    Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
    Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
    Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
    Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.
    Bao R; Wang Y; Lai J; Zhu H; Zhao Y; Li S; Li N; Huang J; Yang Z; Wang F; Liu Z
    Mol Pharm; 2019 Jan; 16(1):339-348. PubMed ID: 30452269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.